Join us   Log in   jmsr2014@yahoo.com  

JOURNAL OF MEDICAL AND SURGICAL RESEARCH - Vol. VI, n 3, February 2020

Pages: 714-721
Print Article   Download XML  Download PDF

CoVID-19: a Digestive Disease!

Author: Cherradi Younes

Category: JMSR Gastroenterology

Abstract:

CoVID-19 is a Public Health Emergency of International Concern. Since the first case has been reported in Wuhan in China, evidence of associated severe acute respiratory syndrome is well established and the disease is accepted as a primarily respiratory infection. However, current available data are supporting a gastrointestinal tropism with great implications at multiple levels in the course of this disease. The gastrointestinal tract appears in the heart of the strategy for management of infected patients from diagnosis to post-recovery isolation policies. This review highlights the digestive aspects of CoVID-19.

Keywords: ACE2, CoVID-19, Digestive, Endoscopy, Fecal transmission, Liver, Prognosis

DOI: 10.46327/msrjg.1.000000000000159

DOI URL: https://doi.org/10.46327/msrjg.1.000000000000159

References:

  1. Statement on the second meeting of the International Health Regulations (2005) Emergency Committee regarding the outbreak of novel coronavirus (2019-nCoV)
  2. Lake MA, What we know so far: COVID-19 current clinical knowledge and research. Clin Med (Lond). 2020 Mar; 20(2):124-127. doi: 10.7861/clinmed.2019-coron.
  3. Wua YC, Chena CS, Chan YJ. The outbreak of COVID-19: An overview. J Chin Med Assoc. March 2020 - Volume 83 - Issue 3 - p 217-220 doi: 10.1097/JCMA.0000000000000270
  4. Hirano T, Murakami M. COVID-19: A New Virus, but a Familiar Receptor and Cytokine Release Syndrome. Immunity. 2020 Apr 19. doi: 10.1016/j.immuni.2020.04.003.
  5. Sarzi-Puttini P, Giorgi V, Sirotti S et al. COVID-19, cytokines and immunosuppression: what can we learn from severe acute respiratory syndrome? Clin Exp Rheumatol. 2020 Mar-Apr; 38(2):337-342.
  6. Mungroo MR, Naveed Ahmed Khan A. and Siddiqui R. Novel Coronavirus: Current Understanding of Clinical Features, Diagnosis, Pathogenesis, and Treatment Options, Pathogens 2020, 9, 297; doi:10.3390
  7. Singhal T. A Review of Coronavirus Disease-2019 (COVID-19) Indian J Pediatr 87, 281–286 (2020). https://doi.org/10.1007/s12098-020-03263-6
  8. Krajewska J., Krajewski W, Zub K et al. COVID?19 in otolaryngologist practice: a review of current knowledge. Eur Arch Otorhinolaryngol (2020). https://doi.org/10.1007/s00405-020-05968-y
  9. Lin L, Jiang X, Zhang Z, et alGastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut April 2020. doi: 10.1136/gutjnl-2020-321013
  10. Hormati A et al., Can COVID-19 present unusual GI symptoms?, Journal of Microbiology, Immunology and Infection, https://doi.org/10.1016/j.jmii.2020.03.020
  11. Jin X, Lian J-­S, Hu JH, et al. Epidemiological, clinical and virological characteristics of 74 cases of coronavirus-infected disease 2019 (COVID-19) with gastrointestinal symptoms. Gut 2020. doi:10.1136/gutjnl-2020-320926
  12. Ka Shing Cheung, Ivan FN. Hung, Pierre PY. Chan et al. Gastrointestinal Manifestations of SARS-CoV-2 Infection and Virus Load in Fecal Samples from the Hong Kong Cohort and Systematic Review and Meta-analysis. Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.03.065
  13. Bajaj A, Purohit HJ. Understanding SARS-CoV-2: Genetic Diversity, Transmission and Cure in Human. Indian J Microbiol. 2020 Apr 20:1-4. doi: 10.1007/s12088-020-00869-4.
  14. 2019–20 coronavirus pandemic Wikipedia: https://en.wikipedia.org/wiki/2019%E2%80%9320_coronavirus_pandemic
  15. Wong SH, Lui RN, Sung JJ.. Covid-19 and the Digestive System. J Gastroenterol Hepatol. 2020 Mar 25. doi: 10.1111/jgh.15047.
  16. Holshue ML, DeBolt C, Lindquist S, et al. First Case of 2019 Novel Coronavirus in the United States. N Engl J Med. 2020; 382: 929-36
  17. Chan JF, Yuan S, Kok KH, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: a study of a family cluster. Lancet. 2020; 395: 514-23
  18. Zhou J, Li C, Zhao G, et al. Human intestinal tract serves as an alternative infection route for Middle East respiratory syndrome coronavirus. Sci Adv 2017; 3 (11). doi: 10.1126/sciadv.aao4966
  19. Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus–infected pneumonia in Wuhan, China. JAMA 2020; published online Feb 7. DOI:10.1001/jama.2020.1585
  20. Yeo C, Kaushal S, Yeo D. Enteric involvement of coronaviruses: is faecal-oral transmission of SARS-CoV-2 possible? Lancet Gastroenterol Hepatol. 2020 Apr; 5(4):335-337. doi: 10.1016/S2468-1253(20)30048-0.
  21. WHO issues consensus document on the epidemiology of SARS. Wkly Epidemiol Rec 2003; 78: 373–75
  22. Xiao F, Tang M., Zheng X et al. Evidence for Gastrointestinal Infection of SARS-CoV-2 Gastroenterology 2020:1–3
  23. S. Musa, Hepatic and gastrointestinal involvement in coronavirus disease 2019 (COVID-19): What do we know till now?, Arab Journal of Gastroenterology, https://doi.org/10.1016/j.ajg.2020.03.002
  24. Lei Pan, Mi Mu, Pengcheng Yang, Yu Sun and al. Clinical Characteristics of COVID-19 Patients with Digestive Symptoms in Hubei, China: A Descriptive, Cross-Sectional, Multicenter Study Lei Pan Am J Gastroenterol 2020; 115:766–773. https://doi.org/10.14309/ajg.0000000000000620
  25. Henry BM., de Oliveira MHS, Benoit J and al. Gastrointestinal symptoms associated with severity of coronavirus disease 2019 (COVID?19): a pooled analysis. Intern Emerg Med. 2020 Apr 17. doi: 10.1007/s11739-020-02329-9.
  26. Guan W-J, Ni Z-Y, Hu Y, et al. Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020. doi:10.1056/NEJMoa2002032.
  27. Mo P, Xing Y, Xiao Y, et al. Clinical characteristics of refractory COVID-19 pneumonia in Wuhan, China. Clin Infect Dis. 2020 Mar 16. pii: ciaa270. doi: 10.1093/cid/ciaa270.
  28. Zhang T, Cui X, Zhao X et al. Detectable SARS-CoV-2 Viral RNA in Feces of Three Children during Recovery Period of COVID-19 Pneumonia. J Med Virol. 2020 Mar 29. doi: 10.1002/jmv.25795.
  29. Tian Y, Rong L, Nian W, He Y. Review article: gastrointestinal features in COVID-19 and the possibility of faecal transmission. Aliment Pharmacol Ther. 2020 May; 51 (9):843-851. doi: 10.1111/apt.15731.
  30. Ong SWX, Tan YK, Chia PY et al. Air, Surface Environmental, and Personal Protective Equipment Contamination by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) From a Symptomatic Patient. JAMA. 2020 Mar 4. doi: 10.1001/jama.2020.3227.
  31. National Health Commission of the People's Republic of China. Guidance on coronavirus disease 2019 (COVID-19), China (Vision 7) (in Chinese). Published online March 3. http://www.gov.cn/zhengce/zhengceku/2020-03/04/content_5486705.htm
  32. Bai Y, Yao L, Wei T. et al. Presumed asymptomatic carrier transmission of COVID-19. JAMA. 2020. Published online Feb 21. https://doi.org/10.1001/jama.2020.2565
  33. Tong Z, Tang A, Li K. et al. Potential presymptomatic transmission of SARS-CoV-2, Zhejiang Province, China, 2020. Emerging Infect Dis 2020;26. https://doi.org/10.3201/eid2605.200198
  34. Ponchon T., Chaudasse S. CoVID19: How to select patients for endoscopy and to reschedule the procedures. Endoscopy International Open. 2020; 08: E699- 700.
  35. Overview of guidance for endoscopy during the coronavirus disease 2019 (COVID-19) pandemic. J. Gastroenterol Hepatol. 2020;35(5):749-759. doi:10.1111/jgh.15053
  36. Mao R, Liang J, Shen J, Ghosh S, Zhu L-R, Yang H et al. Implications of COVID-19 for patients with pre-existing digestive diseases. Lancet Gastroenterol Hepatol 2020; 0:2019–2021.
  37. Rabenau HF, Kampf G, Cinatl J, Doerr HW. Efficacy of various disinfectants against SARS coronavirus. J Hosp Infect 2005; 61: 107–11.
  38. Nelson DB, Muscarella LF. Current issues in endoscope reprocessing and infection control during gastrointestinal endoscopy. World J Gastroenterol 2006; 12: 3953–64.
  39. ASGE Quality Assurance in Endoscopy Committee, Calderwood AH, Day LW, Muthusamy VR, et al. ASGE guideline for infection control during GI endoscopy. Gastrointest Endosc 2018 May; 87 (5):1167–79.
  40. Thesaurus national de cancériologie digestive version du 18/03/2020. www.tncd.org
  41. Xu K, Cai H, Shen Y, Ni et al. Management of corona virus disease-19 (COVID-19): the Zhejiang experience. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020 Feb 21; 49 (1):0.
  42. Behera SS, Ray RC, Zdolec N. Lactobacillus plantarum with Functional Properties: An Approach to Increase Safety and Shelf-Life of Fermented Foods. Biomed Res Int. 2018 May 28; 2018:9361614. doi: 10.1155/2018/9361614.
  43. Liu YS, Liu Q, Jiang YL et al. Surface-displayed porcine IFN-λ3 in Lactobacillus plantarum inhibits porcine enteric coronavirus infection of porcine intestinal epithelial cells. J Microbiol Biotechnol. 2019 Dec 15. doi: 10.4014/jmb.1909.09041.
  44. Zhang C1, Shi L1, Wang FS. Liver injury in COVID-19: management and challenges. Lancet Gastroenterol Hepatol. 2020 May;5(5):428-430. doi: 10.1016/S2468-1253(20)30057-1.
  45. Bangash MN1, Patel J2, Parekh D. COVID-19 and the liver: little cause for concern. Lancet Gastroenterol Hepatol. 2020 Mar 20. pii: S2468-1253(20)30084-4. doi: 10.1016/S2468-1253(20)30084-4.
  46. Yao N, Wang SN, Lian JQ, Sun YT et al. Clinical characteristics and influencing factors of patients with novel coronavirus pneumonia combined with liver injury in Shaanxi region. Zhonghua Gan Zang Bing Za Zhi. 2020 Mar 10;28 (0):E003. doi: 10.3760/cma.j.cn501113-20200226-00070.
  47. Chai X, Hu L, Zhang Y, et al. Specific ACE2 expression in cholangiocytes may cause liver damage after 2019-nCoV infection. bioRxiv 2020; published online Feb 4. https://doi.org/10.1101/2020.02.03.931766.
  48. Koskinas J, Gomatos IP, Tiniakos DG, et al. Liver histology in ICU patients dying from sepsis: a clinico-pathological study. World J Gastroenterol 2008; 14: 1389–93.
  49. Xu Z, Shi L, Wang Y, et al. Pathological findings of COVID-19 associated with acute respiratory distress syndrome. Lancet Respir Med 2020; published online Feb 18. doi:10.1016/S2213-2600(20)30076-X.
  50. Pirola CJ, Sookoian S, COVID-19 and ACE2 in the liver and gastrointestinal tract: Putative biological explanations of sexual dimorphism, Gastroenterology (2020), doi: https://doi.org/10.1053/j.gastro.2020.04.050.
  51. Tukiainen T, Villani AC, Yen A, et al. Landscape of X chromosome inactivation across human tissues. Nature 2017; 550: 244-248.